The death rate of allogeneic peripheral blood transplantation was higher than that of the irradiated group.
在异系间外周血细胞移植，则移植后死亡率明显高于照射对照组。
To summary and analyze the nursing methods of 200 patients received the allogeneic peripheral blood stem cell transplantation.
对200例异基因外周血造血干细胞移植患者护理措施进行总结和分析。
Is the GVHD more severe in the allogeneic peripheral blood stem cell transplantation compared with allogeneic bone marrow transplantation?
异基因外周血干细胞移植中的GVHD比骨髓移植更严重吗？
Objective: To explore the treatment of pure red cell aplasia (PRCA) after ABO-incompatible allogeneic peripheral blood stem cell transplantation.
目的：探讨abo血型不合异基因外周血干细胞移植后纯红细胞再生障碍性贫血(PRCA)的治疗。
Conclusion: Allogeneic peripheral blood stem cell non-myeloablative transplantation can be selectively used in the treatment of metastasis breast cancer.
结论：异基因非清髓性外周血干细胞移植可选择性地应用于晚期乳腺癌的治疗。
The aim of this study was to analyze the hematopoietic chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NAPBSCT).
本研究旨在探讨非清髓异基因外周血造血干细胞移植(NAPBSCT)后造血嵌合体的临床意义。
Objective:To investigate efficacy of unrelated donor allogeneic peripheral blood stem cell transplantation(UD-PBSCT) in treatment of severe aplastic anemia(SAA).
目的：探讨非亲缘供者外周血造血干细胞移植（UD-PBSCT）治疗重型再生障碍性贫血（SAA）的可行性。
Objective To study the role of nonmyeloablative allogeneic peripheral blood stem cell transplantation (NAST) in the treatment of hematological diseases in elderly patients.
目的探讨非清髓异基因外周造血干细胞移植（NAST）在治疗高龄血液病中的作用。
Objective to investigate the clinicopathologic characteristics of renal chronic graft versus host disease (GVHD) after allogeneic peripheral blood hematopoietic transplantation (HSCT).
目的探讨异基因造血干细胞移植(HSCT)后表现在肾脏的慢性移植物抗宿主病(GVHD)的临床及病理特点。
The nursing factors are detected which infect allogeneic peripheral blood haematopoietic stem cell infusion in ABO-major incompatible transplantation or ABO-minor incompatible transplantation.
探讨了护理因素对异基因造血干细胞移植中abo血型主要不合和次要不合的干细胞输注的影响。
Six trials (807 donors) were eligible: all were substudies, or constituent parts of, larger randomised controlled trials of bone marrow and peripheral blood stem cell allogeneic transplantation.
六个研究（807位捐者）被纳入：全部皆是骨髓或周边血干细胞异体移植之随机对照试验的次分析或是部份组成。
Six trials (807 donors) were eligible: all were substudies, or constituent parts of, larger randomised controlled trials of bone marrow and peripheral blood stem cell allogeneic transplantation.
六个研究（807位捐者）被纳入：全部皆是骨髓或周边血干细胞异体移植之随机对照试验的次分析或是部份组成。
应用推荐